Literature DB >> 24418609

γ-Secretase modulators: current status and future directions.

Adrian Hall1, Toshal R Patel2.   

Abstract

This chapter reviews the current status of γ-secretase modulators, highlighting key compounds by each company involved in the area. The review focuses on the three main chemotypes: acids, imidazoles and related derivatives and natural products. A section on chemical biology and ligand-binding site elucidation studies is also included. The primary source of information is drawn from peer reviewed literature as this permits analysis of PK-PD relationships and subsequent comment. Discussion of the patent literature is included for completeness. From this analysis, the key issues and challenges in the area are highlighted. The review concludes with a summary of the clinical development status and comment on future prospects of the field.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; γ-Secretase; γ-Secretase inhibitors; γ-Secretase modulators

Mesh:

Substances:

Year:  2014        PMID: 24418609     DOI: 10.1016/B978-0-444-63380-4.00003-2

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


  14 in total

1.  Fused Morphlinopyrimidines and Methods of Use Thereof.

Authors:  Benjamin Blass
Journal:  ACS Med Chem Lett       Date:  2015-07-13       Impact factor: 4.345

2.  Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability.

Authors:  Martin Pettersson; Douglas S Johnson; John M Humphrey; Todd W Butler; Christopher W Am Ende; Benjamin A Fish; Michael E Green; Gregory W Kauffman; Patrick B Mullins; Christopher J O'Donnell; Antonia F Stepan; Cory M Stiff; Chakrapani Subramanyam; Tuan P Tran; Beth Cooper Vetelino; Eddie Yang; Longfei Xie; Kelly R Bales; Leslie R Pustilnik; Stefanus J Steyn; Kathleen M Wood; Patrick R Verhoest
Journal:  ACS Med Chem Lett       Date:  2015-04-03       Impact factor: 4.345

3.  Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat.

Authors:  Alex E Roher; Chera L Maarouf; Tyler A Kokjohn; Charisse M Whiteside; Walter M Kalback; Geidy Serrano; Christine Belden; Carolyn Liebsack; Sandra A Jacobson; Marwan N Sabbagh; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2014-12-05

Review 4.  A short perspective on the long road to effective treatments for Alzheimer's disease.

Authors:  David S Reynolds
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

Review 5.  Advances in recent patent and clinical trial drug development for Alzheimer's disease.

Authors:  Haibin Liu; Lirong Wang; Weiwei Su; Xiang-Qun Xie
Journal:  Pharm Pat Anal       Date:  2014-07

Review 6.  γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase.

Authors:  Pengju Nie; Abhishek Vartak; Yue-Ming Li
Journal:  Semin Cell Dev Biol       Date:  2020-04-02       Impact factor: 7.727

Review 7.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

8.  Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacy.

Authors:  Martin Pettersson; Douglas S Johnson; Danica A Rankic; Gregory W Kauffman; Christopher W Am Ende; Todd W Butler; Brian Boscoe; Edelweiss Evrard; Christopher J Helal; John M Humphrey; Antonia F Stepan; Cory M Stiff; Eddie Yang; Longfei Xie; Kelly R Bales; Eva Hajos-Korcsok; Stephen Jenkinson; Betty Pettersen; Leslie R Pustilnik; David S Ramirez; Stefanus J Steyn; Kathleen M Wood; Patrick R Verhoest
Journal:  Medchemcomm       Date:  2016-11-02       Impact factor: 3.597

Review 9.  Structural and Chemical Biology of Presenilin Complexes.

Authors:  Douglas S Johnson; Yue-Ming Li; Martin Pettersson; Peter H St George-Hyslop
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 10.  Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways.

Authors:  C Bohm; F Chen; J Sevalle; S Qamar; R Dodd; Y Li; G Schmitt-Ulms; P E Fraser; P H St George-Hyslop
Journal:  Mol Cell Neurosci       Date:  2015-03-04       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.